139 related articles for article (PubMed ID: 32279918)
1. Exploring inflammatory and apoptotic signatures in distinct Crohn's disease phenotypes: Way towards molecular stratification of patients and targeted therapy.
Stankovic B; Dragasevic S; Klaassen K; Kotur N; Srzentic Drazilov S; Zukic B; Sokic Milutinovic A; Milovanovic T; Lukic S; Popovic D; Pavlovic S; Nikcevic G
Pathol Res Pract; 2020 Jun; 216(6):152945. PubMed ID: 32279918
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
[TBL] [Abstract][Full Text] [Related]
3. Ileal Derived Organoids From Crohn's Disease Patients Show Unique Transcriptomic and Secretomic Signatures.
Niklinska-Schirtz BJ; Venkateswaran S; Anbazhagan M; Kolachala VL; Prince J; Dodd A; Chinnadurai R; Gibson G; Denson LA; Cutler DJ; Jegga AG; Matthews JD; Kugathasan S
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1267-1280. PubMed ID: 34271224
[TBL] [Abstract][Full Text] [Related]
4. Role of the advanced glycation end products receptor in Crohn's disease inflammation.
Ciccocioppo R; Vanoli A; Klersy C; Imbesi V; Boccaccio V; Manca R; Betti E; Cangemi GC; Strada E; Besio R; Rossi A; Falcone C; Ardizzone S; Fociani P; Danelli P; Corazza GR
World J Gastroenterol; 2013 Dec; 19(45):8269-81. PubMed ID: 24363518
[TBL] [Abstract][Full Text] [Related]
5. Altered microRNA expression in inflamed and non-inflamed terminal ileal mucosa of adult patients with active Crohn's disease.
Guo Z; Wu R; Gong J; Zhu W; Li Y; Wang Z; Li N; Li J
J Gastroenterol Hepatol; 2015 Jan; 30(1):109-16. PubMed ID: 24910152
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease.
Bamias G; Kaltsa G; Siakavellas SI; Gizis M; Margantinis G; Zampeli E; Vafiadis-Zoumboulis I; Michopoulos S; Daikos GL; Ladas SD
Dig Liver Dis; 2012 Jan; 44(1):30-6. PubMed ID: 21978578
[TBL] [Abstract][Full Text] [Related]
8. Effect of Anti-TNF Therapy on Mucosal Apoptosis Genes Expression in Crohn's Disease.
Lykowska-Szuber L; Walczak M; Skrzypczak-Zielinska M; Suszynska-Zajczyk J; Stawczyk-Eder K; Waszak K; Eder P; Wozniak A; Krela-Kazmierczak I; Slomski R; Dobrowolska A
Front Immunol; 2021; 12():615539. PubMed ID: 33767696
[TBL] [Abstract][Full Text] [Related]
9. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
10. A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn's disease patients.
Li Yim AYF; de Bruyn JR; Duijvis NW; Sharp C; Ferrero E; de Jonge WJ; Wildenberg ME; Mannens MMAM; Buskens CJ; D'Haens GR; Henneman P; Te Velde AA
PLoS One; 2018; 13(12):e0209656. PubMed ID: 30589872
[TBL] [Abstract][Full Text] [Related]
11. Does active Crohn's disease have decreased intestinal antioxidant capacity?
Pinto MA; Lopes MS; Bastos ST; Reigada CL; Dantas RF; Neto JC; Luna AS; Madi K; Nunes T; Zaltman C
J Crohns Colitis; 2013 Oct; 7(9):e358-66. PubMed ID: 23523266
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
13. Alterations in cytokine gene expression profile in colon mucosa of Inflammatory Bowel Disease patients on different therapeutic regimens.
Velikova T; Kyurkchiev D; Spassova Z; Karakolev I; Ivanova-Todorova E; Altankova I; Stanilova S
Cytokine; 2017 Apr; 92():12-19. PubMed ID: 28088612
[TBL] [Abstract][Full Text] [Related]
14. Altered Expression of Angiotensinogen and Mediators of Angiogenesis in Ileal Crohn's Disease.
Hume GE; Doecke JD; Huang N; Fowler EV; Brown IS; Simms LA; Radford-Smith GL
J Gastrointestin Liver Dis; 2016 Mar; 25(1):39-48. PubMed ID: 27014752
[TBL] [Abstract][Full Text] [Related]
15. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
16. RNA-seq Reveals Transcriptomic Differences in Inflamed and Noninflamed Intestinal Mucosa of Crohn's Disease Patients Compared with Normal Mucosa of Healthy Controls.
Hong SN; Joung JG; Bae JS; Lee CS; Koo JS; Park SJ; Im JP; Kim YS; Kim JW; Park WY; Kim YH
Inflamm Bowel Dis; 2017 Jul; 23(7):1098-1108. PubMed ID: 28613228
[TBL] [Abstract][Full Text] [Related]
17. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
[TBL] [Abstract][Full Text] [Related]
18. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease.
Stallmach A; Giese T; Schmidt C; Ludwig B; Mueller-Molaian I; Meuer SC
Int J Colorectal Dis; 2004 Jul; 19(4):308-15. PubMed ID: 14605835
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the mucosa-associated bacterial composition in Crohn's disease: a pilot study.
Schäffler H; Kaschitzki A; Alberts C; Bodammer P; Bannert K; Köller T; Warnke P; Kreikemeyer B; Lamprecht G
Int J Colorectal Dis; 2016 May; 31(5):961-971. PubMed ID: 26951181
[TBL] [Abstract][Full Text] [Related]
20. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
